Reporting owner · Q3 2026 · CIK 1965964

Lin Yu-Hsin: insider trades.

Lin Yu-Hsin reported 21 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 21 sales ($19.1M), across 1 company.

Transactions
21
Purchases (P)
0
Sales (S)
21
Companies
1
Name as filed
Lin Yu-Hsin

Companies

CompanyRelationshipTransactions
Belite Bio, Inc (BLTE)Director, Officer · Chief Executive Officer21

Transactions

21 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-08Belite Bio, IncS6,058$196.5481,586Form 4
2026-09-08Belite Bio, IncS8,752$197.3672,834Form 4
2026-09-08Belite Bio, IncS2,700$198.0970,134Form 4
2026-09-08Belite Bio, IncS2,400$194.3393,734Form 4
2026-09-08Belite Bio, IncS6,090$195.6287,644Form 4
2026-09-04Belite Bio, IncS8,111$193.1396,134Form 4
2026-09-04Belite Bio, IncS2,635$180.29167,934Form 4
2026-09-04Belite Bio, IncS2,587$181.24165,347Form 4
2026-09-04Belite Bio, IncS3,413$182.5161,934Form 4
2026-09-04Belite Bio, IncS4,955$183.3156,979Form 4
2026-09-04Belite Bio, IncS6,252$184.52150,727Form 4
2026-09-04Belite Bio, IncS4,593$185.34146,134Form 4
2026-09-04Belite Bio, IncS7,800$186.32138,334Form 4
2026-09-04Belite Bio, IncS6,200$187.25132,134Form 4
2026-09-04Belite Bio, IncS3,045$188.26129,089Form 4
2026-09-04Belite Bio, IncS8,955$189.34120,134Form 4
2026-09-04Belite Bio, IncS600$190.39119,534Form 4
2026-09-04Belite Bio, IncS11,080$191.15108,454Form 4
2026-09-04Belite Bio, IncS4,209$192.54104,245Form 4
2026-08-12Belite Bio, IncS223$180.57170,569Form 4
2026-08-12Belite Bio, IncS142$180170,792Form 4

Questions

What stock did Lin Yu-Hsin buy or sell?

Lin Yu-Hsin reported 21 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 21 sales ($19.1M), across 1 company.

Is Lin Yu-Hsin the same person as other filers with this name?

This page covers SEC CIK 1965964 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/lin-yu-hsin-1965964.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.